Growth Crushed Profits—The Recovery Timeline Is Missing

On volume, Shakti executed at scale—27,678 solar pump installations, up 57.6% year-on-year, drove revenue to ₹859 crore (+37.9%). The headline looks clean. But net profit fell to ₹51.6 crore, a 46.7% year-on-year decline from ₹97 crore in Q1 FY26. Net profit margin compressed 950 basis points to 5.9% from 15.5%. That gap between growth and profitability is the quarter's real story.

Management quantified the damage: raw material cost inflation contributed ₹36 crore (~6% of operating profit), and lower realization or selling prices another ₹25 crore (~4%). Combined, a ₹61 crore EBITDA hit. Operating profit landed at 9.7%, stable quarter-on-quarter but down 550 basis points year-on-year. The villain: geopolitical headwinds driving steel, copper, and aluminum price spikes, plus pricing pressure in government solar pump tenders where Shakti competes on rate contracts. Management's thesis: temporary.

Order book reset. Prior guidance: ₹1,500 crore. Current (July 22): ₹1,000 crore. A ₹500 crore (~33%) downgrade. KUSUM 2.0, the linchpin scheme for FY27 growth, has not launched—still with the Prime Minister's Office awaiting clearance. No KUSUM orders visible in Q1 despite it being positioned as the quarter's catalyst.

Capex plan locked in. ₹1,500–₹1,700 crore through September 2027: a 0.5 GW solar cell/module plant (September 26), a 2.2 GW integrated facility (September 27), and pump capacity expansion (November 26). ~50% each in FY27 and FY28. Backward integration to supply Shakti's own solar panels is the margin-recovery play in rooftop and pump bundles.

New segments growing but immature. Rooftop solar: ₹8 crore (vs. ₹2 crore prior year), 4x growth but still a small base dependent on the 0.5 GW plant ramp. EV motors (JBM Auto joint venture): in validation phase (8–9 months remaining), zero revenue, meaningful contribution expected FY28 onwards. Cash/retail sales: ₹24 crore with strong trajectory but not yet material.

Margin recovery hedged. Management refused to commit to a 3-year EBITDA target or quantify a margin recovery timeline, citing geopolitical uncertainty. No hedging program for raw material prices despite ₹61 crore of Q1 exposure and acknowledged war-driven supply chain volatility.

The market's initial read was decisively negative and has held. The stock fell 4.25% on day 1 of the result announcement (July 24), deepened to -5.29% by day 3, and settled at -5.9% by day 5. That sustained slide—not a pop-and-fade—reflects sustained skepticism of the margin narrative. Price now sits at ₹520.4, a 37.3% drawdown from its all-time high of ₹829.95. Trading below all major moving averages (SMA20: ₹551.69, SMA50: ₹544.62, SMA200: ₹608.24). RSI at 22.4 signals oversold technicals, but volume is declining—no conviction in a bounce.

Institutional conviction is wavering. Foreign institutional investors trimmed 51 basis points QoQ (FY26 Q4: 4.83% vs. Q3: 5.34%). Domestic institutional investors cut 133 basis points (6.30% → 4.97%). Promoter holding unchanged at ~50.3%, offering no signal of board-level conviction on the reset. The combined flows suggest institutions are cutting losses or pausing until margin recovery becomes visible.

At ₹520.4, the stock trades at a steep discount to prior valuations—down 37.3% from its all-time high and below all long-term moving averages. If earnings hold at ₹51.6 crore quarterly (₹206 crore annualized), the stock sits at roughly 11.5x trailing earnings, a compressed multiple reflecting margin pressure and near-term execution risk. A recovery to ₹100 crore annualized PAT (pre-2024 normalized levels via backward integration and capex) would imply upside, but that outcome is dependent on KUSUM launch, rooftop scaling, and raw material stabilization—all high-execution risks.